Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune responses to influenza vaccinations and viruses among health care personnel
2024-515372-12-00Phase 4Completed
- Sponsor
- Finnish Institute for Health and Welfare
- Start
- Aug 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Fluzone Trivalent in influenza, sponsored by Finnish Institute for Health and Welfare. Started Aug 2024; status: completed.
02
Drugs
Fluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on 2024-515372-12-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515372-12-00.